NEUROTECH INTERNATIONAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.071 AUD | -1.39% |
|
-4.05% | +2.90% |
| Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
| Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEUROTECH INTERNATIONAL LIMITED | Other Biotechnology & Medical Research | -1.39% | -4.05% | +2.90% | +77.50% | +491.67% | 47.96M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- NTI Stock
- Charts Neurotech International Limited
- Comparison Chart
